Association of Bone Mineral Density and Dementia

Background and Objectives Low bone mineral density (BMD) and dementia commonly co-occur in older individuals, with bone loss accelerating in patients with dementia due to physical inactivity and poor nutrition. However, uncertainty persists over the extent to which bone loss already exists before onset of dementia. Therefore, we investigated how dementia risk was affected by BMD at various skeletal regions in community-dwelling older adults. Methods In a prospective population-based cohort study, BMD at the femoral neck, lumbar spine, and total body and the trabecular bone score (TBS) were obtained using dual-energy X-ray absorptiometry in 3,651 participants free from dementia between 2002 and 2005. Persons at risk of dementia were followed up until January 1, 2020. For analyses of the association between BMD at baseline and the risk of incident dementia, we used Cox proportional hazards regression analyses, adjusting for age, sex, educational attainment, physical activity, smoking status, body mass index, systolic and diastolic blood pressure, cholesterol level, high-density lipoprotein cholesterol, history of comorbidities (stroke and diabetes mellitus), and APOE genotype. Results Among the 3,651 participants (median age 72.3 ± 10.0 years, 57.9% women), 688 (18.8%) developed incident dementia during a median of 11.1 years, of whom 528 (76.7%) developed Alzheimer disease (AD). During the whole follow-up period, participants with lower BMD at the femoral neck (per SD decrease) were more likely to develop all-cause dementia (hazard ratio [HR] total follow-up 1.12, 95% CI 1.02–1.23) and AD (HRtotal follow-up 1.14, 95% CI 1.02–1.28). Within the first 10 years after baseline, the risk of dementia was greatest for groups with the lowest tertile of BMD (femoral neck BMD, HR0–10 years 2.03; 95% CI 1.39–2.96; total body BMD, HR0–10 years 1.42; 95% CI 1.01–2.02; and TBS, HR0–10 years 1.59; 95% CI 1.11–2.28). Discussion In conclusion, participants with low femoral neck and total body BMD and low TBS were more likely to develop dementia. Further studies should focus on the predictive ability of BMD for dementia.

[1]  D. Kiel,et al.  Osteoporosis and Dementia: Establishing a Link , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  P. Geusens,et al.  Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  D. Hans,et al.  DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis , 2021, Endocrine.

[4]  J. Carrero,et al.  Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults , 2021, Neurology.

[5]  S. Kardia,et al.  Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort , 2021, Neurology: Genetics.

[6]  S. Murata,et al.  Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease: A Retrospective Cohort Study at a Japanese Memory Clinic. , 2020, Alzheimer disease and associated disorders.

[7]  Brenda C T Kieboom,et al.  Objectives, design and main findings until 2020 from the Rotterdam Study , 2020, European Journal of Epidemiology.

[8]  C. Dengler-Crish,et al.  Mechanistic complexities of bone loss in Alzheimer’s disease: a review , 2020, Connective tissue research.

[9]  Jae Min Kim,et al.  Association between bone mineral density and brain parenchymal atrophy and ventricular enlargement in healthy individuals , 2019, Aging.

[10]  M. Ikram,et al.  Genetic predisposition, modifiable risk factor profile and long-term dementia risk in the general population , 2019, Nature Medicine.

[11]  H. Ryu,et al.  Bone mineral loss and cognitive impairment , 2018, Medicine.

[12]  L. Jacob,et al.  Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany. , 2018, Journal of Alzheimer's disease : JAD.

[13]  R. Payne,et al.  Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study , 2017, BMJ Open.

[14]  M. Carrillo,et al.  Research priorities to reduce the global burden of dementia by 2025 , 2016, The Lancet Neurology.

[15]  Zhongheng Zhang,et al.  Multiple imputation with multivariate imputation by chained equation (MICE) package. , 2016, Annals of translational medicine.

[16]  Fracture as an Independent Risk Factor of Dementia: A Nationwide Population-Based Cohort Study: Erratum , 2016, Medicine.

[17]  M. Boyanov WHOLE BODY AND REGIONAL BONE MINERAL CONTENT AND DENSITY IN WOMEN AGED 20-75 YEARS. , 2016, Acta endocrinologica.

[18]  J. Reginster,et al.  Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. , 2015 .

[19]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[20]  P. Vemuri,et al.  Sex and gender differences in the causes of dementia: a narrative review. , 2014, Maturitas.

[21]  Huadong Zhou,et al.  Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer's disease. , 2014, Current Alzheimer research.

[22]  E. M. Lewiecki,et al.  Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis International.

[23]  Y. Minn,et al.  Osteoporosis as an independent risk factor for silent brain infarction and white matter changes in men and women: the PRESENT project , 2014, Osteoporosis International.

[24]  B. Liu,et al.  Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function. , 2014, Bone.

[25]  Molly Fox,et al.  Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women , 2013, Psychoneuroendocrinology.

[26]  L. Mei,et al.  Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N‐acetyl‐L‐cysteine , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Po H. Lu,et al.  Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responses. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[28]  Liang Shen,et al.  Alzheimer's Disease and Risk of Hip Fracture: A Meta-Analysis Study , 2012, TheScientificWorldJournal.

[29]  G. Greendale,et al.  Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women's Health Across the Nation (SWAN) , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  W. Leslie,et al.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  T. Trikalinos,et al.  Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis , 2011, Osteoporosis International.

[32]  Claes Ohlsson,et al.  Regulation of adult bone turnover by sex steroids , 2010, Journal of cellular physiology.

[33]  M. Hiligsmann,et al.  Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women , 2009, European Journal of Epidemiology.

[34]  L. Pothuaud,et al.  Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. , 2009, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[35]  A. Tenenhouse,et al.  Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents , 2008, Canadian Medical Association Journal.

[36]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[37]  J. Janowsky,et al.  Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.

[38]  D. Drachman,et al.  Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. , 2001, Archives of neurology.

[39]  A Hofman,et al.  Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study , 2000, Clinical endocrinology.

[40]  A Hofman,et al.  Risk factors for increased bone loss in an elderly population: the Rotterdam Study. , 1998, American journal of epidemiology.

[41]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.

[42]  R. Helme,et al.  Bone Density, Vitamin D Nutrition, and Parathyroid Hormone Levels in Women with Dementia , 1995, Journal of the American Geriatrics Society.

[43]  J. Wishart,et al.  Effect of age on bone density and bone turnover in men , 1995, Clinical endocrinology.

[44]  F. Mastaglia,et al.  The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.

[45]  Huadong Zhou,et al.  Association between bone mineral density and the risk of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[46]  W. Brooks,et al.  Bone density and brain atrophy in early Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[47]  D. Kiel,et al.  Bone mineral density and the risk of Alzheimer disease. , 2005, Archives of neurology.

[48]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6. , 1992, Science.